Trade ACXP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Acurx Pharmaceuticals, Inc. (ACXP) is trading at US$1.38, up 1.48% today as of Sep 16, 11:27 EDT. The company has a market capitalisation of US$6.32M. Over the past 52 weeks, ACXP has traded between US$1.31 and US$8.34. On Syfe you can trade ACXP with $0 commission and add it to your watchlist.
| Previous close | US$1.36 |
|---|---|
| Market cap | US$6.32M |
| 52-week range | US$1.31 – US$8.34 |
| Volume | 81.5K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.
Year: 2021
Top Premarket Gainers
Mar 24, 11:16 AM · MT Newswires
Acurx Pharmaceuticals, Inc. (ACXP) stock is trading at US$1.38, +1.48% from the previous close of US$1.36.
The market cap for Acurx Pharmaceuticals, Inc. (ACXP) stock is approximately US$6.32M.
The 52-week high for Acurx Pharmaceuticals, Inc. (ACXP) stock is US$8.34.
The 52-week low for Acurx Pharmaceuticals, Inc. (ACXP) stock is US$1.31.
Acurx Pharmaceuticals, Inc. (ACXP) does not currently pay a dividend.
Stay on top of ACXP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
